Bayesian mixed-effects model

Enhancing Treatment Evaluation in Fibrotic Interstitial Lung Disease: A Joint Model of Lung Function Decline and Mortality

This article reviews a novel Bayesian joint mixed-effects model for analyzing lung function decline and mortality in fibrotic ILD, improving accuracy in estimating disease progression and treatment effects in clinical settings.